Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Reliq Health Technologies Inc V.RHT.H

Alternate Symbol(s):  RQHTF

Reliq Health Technologies Inc. is a global healthcare technology company that specializes in developing virtual care solutions for the healthcare market. The Company’s iUGO Care platform supports care coordination and community-based virtual healthcare. iUGO Care allows complex patients to receive care at home, improving health outcomes, enhancing quality of life for patients and families and reducing the cost of care delivery. iUGO Care provides real-time access to remote patient monitoring data, allowing for timely interventions by the care team to prevent hospital readmissions and ER visits. The iUGO Care platform integrates wearables, sensors, voice technology and mobile apps and desktop user interfaces for patients, clinicians and healthcare administrators. The iUGO Care platform provides services, such as remote patient monitoring, chronic care management, principal care management, behavioral health integration, telemedicine, transitional care management, wound care, and others.


TSXV:RHT.H - Post by User

Comment by lscfaon Dec 01, 2021 8:56am
166 Views
Post# 34184140

RE:Review of Q1

RE:Review of Q1

Revenue for sept qtr was $1.6 million and a/r increased $1.75 million. Reliq did not collect 1 cent. Reliq is getting played by these clients who had access to US govt. Covid grants.

https://www.ama-assn.org/delivering-care/public-health/summary-paycheck-protection-program-and-health-care-enhancement-act



Gulliver1909 wrote: After reviewing the first quarter numbers in general I am happy as the growth story is ongoing. Should lead to higher prices in the coming months - if the markets keep stable.

Three aspects things I didn´t like:

1) Heavy dilution by 8 million shares. When you review the quarterly results they paid their consultants immediately valid options in the amount of 1-2 million $ per quarter for the last 12 months or so. Hopefully that comes to an end soon. No indication about how they are going to proceed in that aspect. Which consultants get these shares for what kind of service?

2) Following Q4 2021 in her webcast Dr. Crossley guided for 11 million $ revenue in calendar year 2021 - that does not seem to be achievable anymore.

3) Some receivables are longer lasting than 3 months - so I assume the medical customers got paid by medicare/medicaid already. Why didnt they pass over their fee to Reliq? I think originally Dr. Crossley already guided (in the September webcast) that this receivables should have been collected at the end of first quarter (September 30th)?!



 

<< Previous
Bullboard Posts
Next >>